↓ Skip to main content

Case report: Dual dabrafenib and trametinib therapy for treating BRAF V600E mutated lung adenocarcinoma with BRCA2 germline mutation post multiline progression

Overview of attention for article published in Frontiers in oncology, April 2024
Altmetric Badge

Mentioned by

reddit
1 Redditor

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Case report: Dual dabrafenib and trametinib therapy for treating BRAF V600E mutated lung adenocarcinoma with BRCA2 germline mutation post multiline progression
Published in
Frontiers in oncology, April 2024
DOI 10.3389/fonc.2024.1387388
Pubmed ID
Authors

Huimin Zhang, Xiaofeng Cong, Jiaxin Yin, Chen Chen, Ziling Liu

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 6 67%
Researcher 1 11%
Other 1 11%
Unknown 1 11%
Readers by discipline Count As %
Unspecified 6 67%
Environmental Science 1 11%
Medicine and Dentistry 1 11%
Unknown 1 11%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 May 2024.
All research outputs
#23,229,566
of 25,887,951 outputs
Outputs from Frontiers in oncology
#16,279
of 22,829 outputs
Outputs of similar age
#167,734
of 210,355 outputs
Outputs of similar age from Frontiers in oncology
#217
of 271 outputs
Altmetric has tracked 25,887,951 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,829 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,355 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 271 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.